# HPV type16/18 L1 protein

## Cervarix HPV 0.5mL/dose

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ICER                                                                                                                                                                                                                                                                                                                                   |
| Indications        | Prevention of cervical cancer in females 10-25 years， by protecting against incident & persistent infections， cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) & cervical intraepithelial neoplasia (CIN)， CIN1 & pre-cancerous lesions (CIN2 & CIN3) caused by HPV Types 16 & 18. |
| Dosing             | IM， 0.5mL， > or = 15 years 3 doses at 0， 1， and 6 months. 9-14 years can take 3 doses at 0， 1， and 6 months or 2 doses at 0 and 6-12 months.                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Subjects with known hypersensitivity to any component of Cervarix.                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Headache， GI disturbances， itch， rash， myalgia， arthralgia， inj site reactions， fatigue， fever.                                                                                                                                                                                                                                |
| Pregnancy          | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                          |

## Cervarix (HPV，Government) 0.5mL/dose

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ICER0                                                                                                                                                                                                                                                                                                                                  |
| Indications        | Prevention of cervical cancer in females 10-25 years， by protecting against incident & persistent infections， cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) & cervical intraepithelial neoplasia (CIN)， CIN1 & pre-cancerous lesions (CIN2 & CIN3) caused by HPV Types 16 & 18. |
| Dosing             | IM， 0.5mL， > or = 15 years 3 doses at 0， 1， and 6 months. 9-14 years can take 3 doses at 0， 1， and 6 months or 2 doses at 0 and 6-12 months.                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Subjects with known hypersensitivity to any component of Cervarix.                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Headache， GI disturbances， itch， rash， myalgia， arthralgia， inj site reactions， fatigue， fever.                                                                                                                                                                                                                                |
| Pregnancy          | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                          |

